Pulmonary Hypertension Clinical Trial
Official title:
Screening for Pulmonary Vascular Changes in Patients With Chronic Myeloproliferative Diseases
Goal of the study is to assess the frequency of pulmonary hypertension in patients with
chronic myeloproliferative diseases. In each patient an echocardiography at rest will be
performed. In patients without musculoskeletal disease an exercise test (spiroergometry)
will be performed. Patients with elevated SPAP at rest or with reduced exercise capacity
(peak VO2 < 65%) a right heart catheterization (RHC) will be recommended. Also patients with
advanced NYHA functional class (III or IV) or with typical PH findings in electrocardiogram
will be advised to undergo a RHC. Additionally for the evaluation of exercise capacity a 6
MWD will be performed.
This work- up of patients allows clinical and hemodynamic evaluation.
Previous small studies and clinical cases have suggested a possible association between
pulmonary hypertension (PH) and chronic myeloproliferative disorders (CMPD). MPD may cause
PH through different mechanisms as: high cardiac output, asplenia, direct obstruction of
pulmonary arteries by megakaryocytes, chronic thromboembolic endothelial pulmonary
hypertension (CTEPH), porto-pulmonary hypertension (POPH). However, the exact prevalence of
PH in this group of disorders is not known.
This study is designed to identify the pulmonary vascular changes and describe the
prevalence of pulmonary hypertension (defined in this study as mean pulmonary arterial
hypertension (mPAP) ≥25mmHg as assessed by right-heart catheterization (RHC) or systolic
pulmonary arterial pressure (sPAP) ≥37mmHg (2.9 m/s) assessed by echocardiography.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT01950585 -
Hydroxyurea in Pulmonary Arterial Hypertension
|
Early Phase 1 | |
| Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
| Completed |
NCT03649932 -
Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing
|
Phase 1 | |
| Recruiting |
NCT04554160 -
Arrhythmias in Pulmonary Hypertension Assessed by Continuous Long-term Cardiac Monitoring
|
||
| Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
| Completed |
NCT01894035 -
Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation
|
||
| Not yet recruiting |
NCT04083729 -
Persistent Pulmonary Hypertension After Percutaneous Mitral Commissurotomy
|
N/A | |
| Terminated |
NCT02246348 -
Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)
|
N/A | |
| Terminated |
NCT02243111 -
Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound
|
N/A | |
| Completed |
NCT02821156 -
Study on the Use of Inhaled NO (iNO)
|
N/A | |
| Completed |
NCT02216279 -
Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension
|
Phase 2 | |
| Recruiting |
NCT01913847 -
Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension
|
Phase 3 | |
| Completed |
NCT06240871 -
Contrast Enhanced PA Pressure Measurements
|
||
| Completed |
NCT01615484 -
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
|
N/A | |
| Completed |
NCT02377934 -
Evaluation of Radiation Induced Pulmonary Hypertension Using MRI in Stage III NSCLC Patients Treated With Chemoradiotherapy. A Pilot Study
|
||
| Recruiting |
NCT01091012 -
Effectiveness of the Vasodilator Test With Revatio, Made in Patients With Acute Pulmonary Hypertension
|
Phase 3 | |
| Completed |
NCT00739375 -
The Effect of Blood Flow in the Maturing Arteriovenous Access for Hemodialysis on the Development of Pulmonary Hypertension.
|
Phase 1 | |
| Completed |
NCT01484899 -
Smoking: a Risk Factor for Pulmonary Arterial Hypertension?
|
N/A | |
| Completed |
NCT01463514 -
Noninvasive Determination of Cerebral Tissue Oxygenation in Pulmonary Hypertension
|
N/A | |
| Completed |
NCT02275793 -
The Regulation of Pulmonary Vascular Resistance in Patients With Heart Failure
|